FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
Links shared publicly online about this topic.
- 1,722total visits
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
View full resource at drugs.com
Tags: Diabetes Type 2 Medication, FDA, Januvia
Most Recently Shared on September 26, 2009 at 4:42 am By:
FDA Alert - FDA Revises Januvia/Janumet Prescribing Information to Include Reported Cases of Acute Pancreatitis - http://bit.ly/QlRRO
FDA links Januvia to pancreatitis - FiercePharma
fiercepharma.com — “Concerned by post-marketing cases of pancreatitis, FDA is adding the reports to labeling on Merck's (MRK) diabetes drug Januvia (sitagliptin) and a combo form of the drug, Janumet. The agency is... Read more...” View full resource at fiercepharma.com
Most Recently Shared on September 30, 2009 at 6:48 pm By:
RT @safety_alertss: #Drug #PtSafety #FDA links Januvia to pancreatitis Merck's #diabetes medication, new use #labeling. http://ow.ly/rLrk
Advertisement
